Modified intention-to-treat (ITT) and on-treatment analyses were consistent with the overall ... and no other indication for ...

Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

In this retrospective cohort of patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement ...

The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

Cadrenal Therapeutics, Inc., (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and superior ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

1 Despite strong evidence that treatment with direct oral anticoagulants prevents first ever stroke in people with atrial fibrillation, when to commence anticoagulation in patients with acute ...

Tom Nolan reviews this week’s research Trials of direct oral anticoagulants for atrial fibrillation have excluded patients with acute ischaemic stroke because of concerns over the risk of haemorrhagic ...

Despite the high burden of coagulopathy that have a negative impact on AP patients’ prognosis, there is no effective treatment yet. Although a variety of anticoagulants drugs have been evaluated in ...